Condition
Esophageal Disease
Total Trials
6
Recruiting
1
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (2)
Trial Status
Completed5
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT02526095RecruitingPrimary
The French EsoGastricTumours Data Base
NCT04001400Phase 3CompletedPrimary
Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux.
NCT03998969Phase 3CompletedPrimary
Efficacy of DA-5204 on Gastroesophageal Reflux Disease
NCT02105506Not ApplicableCompletedPrimary
Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses
NCT01927016Completed
Outcomes After Esophageal Cancer Surgery
NCT01360515Completed
A Study of Disposable Transnasal Esophagoscope
Showing all 6 trials